Abstract
Non-myeloablative conditioning hematopoietic cell transplantation (NMC-HCT) has improved the treatment of chronic lymphocytic leukemia (CLL) and follicular lymphoma (FL). In a cohort of 85 patients (45 with CLL and 40 with FL), we observed 5-yr overall survival (OS) and progression-free survival (PFS) of 53% and 38% in the CLL group and 81% and 76% in the FL group. In the both the CLL group and the FL group, a strong trend toward better OS and PFS was observed among patients in complete remission (CR) at HCT. Within the FL group, sixteen patients had at one or more time points in their disease history had transformed FL. In contrast to the poor survival found in patients with transformed FL in previous studies, the 5-yr OS was almost identical in patients with transformed and non-transformed FL, 83% and 78%, respectively. In conclusion, our study supports that NMC-HCT is a safe and efficacious treatment that can provide long-term survival in elderly, heavily pretreated patients with FL and CLL. Especially patients with FL, and also transformed FL, seemed to have a great benefit of NMC-HCT, and CR at the time of HCT was an important prognostic factor.
References
Jan 1, 1991·The Journal of Dermatology·K TanakaA Tanaka
Feb 1, 1996·Annals of Internal Medicine·M MichalletR P Gale
Feb 5, 1998·British Journal of Haematology·C M MandigersT De Witte
May 23, 2001·Blood·P A McSweeneyR F Storb
Jun 12, 2002·Bone Marrow Transplantation·K C DoneyUNKNOWN Seattle Bone Marrow Transplant Team
Aug 27, 2002·Cytotherapy·I F KhouriR E Champlin
Apr 28, 2004·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Søren L PetersenLars L Vindeløv
Aug 12, 2004·Blood·Emma MorrisStephen Mackinnon
Mar 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frédéric BaronRainer Storb
Jul 5, 2005·Blood·Mohamed L SorrorBarry Storer
Jul 27, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven Z PavleticClaudio Anasetti
May 10, 2007·Haematologica·Stéphane VigourouxUNKNOWN French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)
Aug 21, 2007·Best Practice & Research. Clinical Haematology·Thorsten ZenzStephan Stilgenbauer
Dec 7, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew R RezvaniDavid G Maloney
Jan 25, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Parameswaran HariKoen van Besien
Feb 5, 2008·Bone Marrow Transplantation·B KornblitL Vindeløv
Apr 3, 2008·American Journal of Hematology·Tania N MasmasLars L Vindeløv
Apr 16, 2008·Blood·Issa F KhouriRichard E Champlin
Sep 17, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mohamed L SorrorDavid G Maloney
Oct 2, 2009·British Journal of Haematology·Irit AviviUNKNOWN EBMT Lymphoma Working Party
Jan 29, 2010·Haematologica·José Luis PiñanaUNKNOWN GELTAMO Group
Jun 30, 2010·Leukemia & Lymphoma·Aline ClavertMohamad Mohty
Jul 8, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kirsty J ThomsonStephen Mackinnon
Aug 13, 2010·Leukemia·M MichalletUNKNOWN Chronic Leukemia Working Party of the EBMT
Feb 8, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Thomas SheaUNKNOWN Cancer and Leukemia Group B
May 31, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Nishitha Reddy, Bipin N Savani